Literature DB >> 28695756

Double carbapenem therapy (DCT) for bacteremia due to carbapenem-resistant Klebsiella pneumoniae (CRKP): from test tube to clinical practice.

Veena Venugopalan1, Boris Nogid2, Thy N Le3, Shafiqur M Rahman4, Tiffany E Bias5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28695756     DOI： 10.1080/23744235.2017.1350880

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN： 2374-4243


× No keyword cloud information.
  4 in total

1.  XDR-Klebsiella pneumoniae isolates harboring blaOXA-48: In vitro and in vivo evaluation using a murine thigh-infection model.

Authors:  Noha A Kamel; Wafaa N El-Tayeb; Mona R El-Ansary; Mohamed T Mansour; Khaled M Aboshanab
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-31

2.  Role of Double-Carbapenem Regimen in the Treatment of Infections due to Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae: A Single-Center, Observational Study.

Authors:  F Cancelli; A Oliva; M De Angelis; M T Mascellino; C M Mastroianni; V Vullo
Journal:  Biomed Res Int       Date:  2018-11-18       Impact factor: 3.411

Review 3.  Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections.

Authors:  Beatriz Suay-García; María Teresa Pérez-Gracia
Journal:  Antibiotics (Basel)       Date:  2019-08-19

4.  Mortality, clinical and microbiological response following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections (a meta-analysis dataset).

Authors:  Akosua A Agyeman; Phillip J Bergen; Gauri G Rao; Roger L Nation; Cornelia B Landersdorfer
Journal:  Data Brief       Date:  2019-11-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.